Navigation Links
ACC Concerned Over Reporting of Biomonitoring Results
Date:10/23/2007

inform us about how the chemical was introduced, how long it has been there, or whether it poses any health risk what so ever. It would be erroneous to suggest that just because effects can be observed in toxicity studies at high doses of a chemical, that the same effects would occur at much, much lower doses.

The chemical industry recognizes that environmental health issues represent a legitimate concern, and we both recognize and act on our responsibility to help preserve a healthy environment, not only for our own children, but also for future generations. This is a fundamental responsibility we take seriously. ACC members meet this responsibility through compliance with a network of regulatory safeguards including many federal and state laws and through voluntary programs, such as Responsible Care(R), the HPV Challenge and the Voluntary Children's Chemical Evaluation Program Pilot. (VCCEP). Annually, our industry invests over $26 billion on research and innovation, $14 billion on complying with the dozens of federal, and hundreds of state regulations that govern the products, processes and distribution of the products of chemistry, and above that ACC members have invested over $120 million over the past five years in research to evaluate health and environmental impacts of chemicals -- much of which relates to the interpretation of biomonitoring data.

To Learn More About Biomonitoring and Responsible Reporting of Results:

Centers for Disease Control and Prevention

http://www.cdc.gov/exposurereport/

National Academy of Sciences

http://www.nap.edu/catalog.php?record_id=11700

BiomonitoringInfo.Org http://www.biomonitoringinfo.org

http://www.americanchemistr
'/>"/>

SOURCE American Chemistry Council
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
2. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
6. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
7. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... CARLSBAD, Calif. , May 4, 2015  Isis ... an exclusive license agreement with Bayer HealthCare (Bayer) to ... of thrombosis. Under the terms of the agreement, Isis ... near-term payments, including an immediate $100 million up-front payment ... program following a Phase 2 study in patients with ...
(Date:5/4/2015)... NEW YORK , May 4, 2015  FireflySci Inc., the newest member of the ... months after launch, they have turned the cuvette industry on its head by offering scientists amazing ... http://photos.prnewswire.com/prnh/20150501/213243LOGO Photo - http://photos.prnewswire.com/prnh/20150501/213244 ... ... ...
(Date:5/4/2015)... 2015 Intarcia Therapeutics, Inc. ... into the newly created role of Chief ... pharmaceutical executive with world-class experience – most recently ... service at industry leaders such as Pfizer and ... range of therapeutic areas, including: cardiovascular, metabolic, oncology, ...
Breaking Medicine Technology:Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 2New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 2Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 4
(Date:5/4/2015)... In response to the proposed mammography ... (USPSTF), Strategic Radiology® (SR®) fully aligns itself with ... Gynecologists (ACOG), the American College Of Surgeons, Susan ... (ACS), American College of Radiology (ACR), and Society ... screening mammography for women beginning at age 40 ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 For partners ... brand new lubricant -- Astroglide TTC™ (Trying to ... motility and alter pH levels, Astroglide TTC™ is specially ... , According to the Centers for Disease Control, an ... trouble getting pregnant or sustaining a pregnancy, and over ...
(Date:5/4/2015)... CA (PRWEB) May 04, 2015 Fast ... Eric Gladen’s documentary Trace Amounts, and Allison Folmar, JD, ... autism conference held internationally. , On Sunday, May 24, ... recovery from autism possible?" Are you interested in Ryan ... In There: winning our war against autism was ...
(Date:5/4/2015)... 2015 “St. Louis has long represented ... the West,” so it is the perfect place for ... Dr. Ben Litalien, Chief Development Officer for Zerorez. ... and will provide veterans with a $10,000 discount on ... to have a number of Military Veterans in its ...
(Date:5/3/2015)... 2015 AvePoint, the ... and devices, today announced it is a Platinum ... (IAPP) Asia Privacy Forum, taking place May 5-6, ... event, AvePoint will showcase its compliance, risk, and ... , Visit AvePoint for New Solutions , ...
Breaking Medicine News(10 mins):Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 2Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 3Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 4Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 5Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 2Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 3Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 3Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 4Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 2Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 3Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 2Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 3Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 4
... an Increase in the, Number of Patients Treated for Low ... Surveyed MCOs Will Not Add Novel HDL Drugs to Their ... According to a New Report from Decision Resources, ... leading research and advisory firms for pharmaceutical and,healthcare issues, finds ...
... are concerned about access to care for seniors, and ... Medicare patients,according to a new public poll released today ... payments to physicians will be cut,10.6 percent, and over ... 40,percent while medical practice costs increase 20 percent., ...
... PITTSBURGH, March 19 To develop new strategies to ... of the worlds population and kills almost two million ... Vaccine Research has received an $11.4 million grant from ... enable Pitt researchers to use new imaging technologies to ...
... 19 Goosie, LLC announced today,that they will ... throughout the month of April with a series ... autistic children with special,discounts. Goosie is the market ... Cards are created online at http://www.goosiecards.com ...
... UMDNJ has received a grant for the UMDNJ-University Hospital ... Federation (IDF) BRIDGES program to tailor interventions to improve ... 2 diabetes. , The academic teaching hospital provides ... found that many of its patients never connect to ...
... follow a genetic program independent of developing tissue , , ... concept of how the brain,s blood supply develops is ... researchers. , In experiments with mice, the researchers found ... their own agenda beginning early in fetal development. They ...
Cached Medicine News:Health News:One-Third of U.S. Primary Care Physicians and Cardiologists Do Not Currently Prescribe Treatment to Meet HDL Cholesterol Targets as Recommended By National Guidelines 2Health News:One-Third of U.S. Primary Care Physicians and Cardiologists Do Not Currently Prescribe Treatment to Meet HDL Cholesterol Targets as Recommended By National Guidelines 3Health News:New Poll Shows Public Worried About Medicare Cuts Impact on Seniors, Boomers - Wants Congress To Act 2Health News:Stopping a deadly killer 2Health News:Goosie Cards to Support Autism Awareness Month With Special Discount Program 2Health News:International Diabetes Federation gives grant to UMDNJ-University Hospital in Newark 2Health News:International Diabetes Federation gives grant to UMDNJ-University Hospital in Newark 3Health News:Brain Blood Vessels Grow With Their Own Agenda 2
The Olympus full range of laparoscopes includes a range of diameters and directions of view -12 mm HDTV compatible model as well as a choice of 10 mm, 5 mm full screen and 3 mm....
The flexible nature of the vinyl allows the user to reach deeper into the chamber and allows for a greater comfort when working inside the glove box over a long period of time compared to any rigid s...
Compact, economical Bactron II anaerobic environment system with air lock, workspace and a 200 plate capacity incubator delivers optimum productivity in a compact space....
This chamber is designed to provide a large workspace and gloveless dexterity in closed environment industrial, research and development, quality control packaging applications. Atmospheres of nitrog...
Medicine Products: